Immunotherapy is a type of cancer treatment. It uses your body’s immune system to prevent, control, and get rid of cancer. It helps your body recognize and attack cancer cells, boosts immune cells that destroy cancer, and improves your body’s immune response.
How Does Immunotherapy Work?
Pembrolizumab (Keytruda) is a type of immunotherapy. Right now it’s only approved for some types of ovarian cancer. You get this treatment in an IV every 3 weeks. Pembrolizumab allows your immune cells to recognize proteins on cancer cells. If you have advanced ovarian cancer, ask your doctor if a clinical trial with this treatment could help.
Immunotherapy can offer long-term control over your ovarian cancer. This treatment trains your immune system to remember cancer cells. This “memory” can allow for longer lasting, or even permanent protection from cancer.
Who Gets Immunotherapy for Ovarian Cancer?
Although immunotherapy doesn’t work for everyone, it’s quickly becoming an option for people with returning ovarian cancer.
Doctors can improve your overall health outcome by using immunotherapy with other ovarian cancer treatments like:
Possible Side Effects
Immunotherapy treatment might cause some side effects. Less serious ones can include:
Other serious side effects are much less common. They include:
Immunotherapy could cause an autoimmune reaction. This is rare, but it could lead to serious or even life-threatening issues in your lungs, liver, hormone-making glands, intestines, kidneys, or other organs.
If you notice any changes or reactions after you get immunotherapy, report them to the doctor right away. If a serious side effect happens, you might need to stop treatment.